Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI ...

PET/CT scans using an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify SC nodal metastasis ...

FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than ... or being referred for unnecessary MRI scans, invasive biopsies and other treatments.

According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.

It is a kit that is used for preparing gallium-68 (⁶⁸Ga) gozetotide injection for PET imaging in conjunction with ...

It is the first randomised trial to compare microUS procedures with MRI ones specifically for prostate cancer. As part of ... to capture similar detail to MRI scans for targeted biopsies.

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of ...

Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...